Low serum adiponectin predicts 10-year risk of type 2 diabetes and hba1c independently of obesity, lipids, and inflammation: Whitehall II study

Hormone and Metabolic Research

Volumn 41, Issue 8, 2009, Pages 626-629

  Tabak A G ^a,b   Brunner, E J ^a   Miller, M A ^c   Karanam, S ^c   McTernan, P G ^c   Cappuccio, F P ^c   Witte, D R ^a,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d STENO DIABETES CENTER   (Denmark)

Author keywords

Adipokines; C reactive protein; Follow up studies; Glycosylated; Haemoglobin A

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; HEMOGLOBIN A1C; LIPID; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BODY MASS; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLUCOSE TOLERANCE TEST; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; BLOOD; CASE CONTROL STUDY; COHORT ANALYSIS; INFLAMMATION; LIPID METABOLISM; METABOLISM; MIDDLE AGED; PREDICTION AND FORECASTING; RISK FACTOR;

ADIPONECTIN; ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFLAMMATION; LIPID METABOLISM; MALE; MIDDLE AGED; OBESITY; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 70349580117     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0029-1216359     Document Type: Article

References (15)

1. Fischer-Posovszky P, Wabitsch M, Hochberg Z. Endocrinology of adipose tissue an update. Horm Metab Res 2007 39 314-321
2. Oh DK, Ciaraldi T, Henry RR. Adiponectin in health and disease. Diabetes Obes Metab 2007 9 282-289
3. Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, Ohnuma H, Igarashi M, Tominaga M, Kato T. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study. Diabetes Care 2003 26 2015-2020
4. Duncan BB, Schmidt MI, Pankow JS, Bang H, Couper D, Ballantyne CM, Hoogeveen RC, Heiss G. Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2004 53 2473-2478 (Pubitemid 39145606)
5. Koenig W, Khuseyinova N, Baumert J, Meisinger C, Lowel H. Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany. J Am Coll Cardiol 2006 48 1369-1377
6. Krakoff J, Funahashi T, Stehouwer CD, Schalkwijk CG, Tanaka S, Matsuzawa Y, Kobes S, Tataranni PA, Hanson RL, Knowler WC, Lindsay RS. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care 2003 26 1745-1751
7. Mather KJ, Funahashi T, Matsuzawa Y, Edelstein S, Bray GA, Kahn SE, Crandall J, Marcovina S, Goldstein B, Goldberg R. Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program. Diabetes 2008 57 980-986
8. Snijder MB, Heine RJ, Seidell JC, Bouter LM, Stehouwer CD, Nijpels G, Funahashi T, Matsuzawa Y, Shimomura I, Dekker JM. Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the Hoorn study. Diabetes Care 2006 29 2498-2503
9. Wannamethee SG, Lowe GD, Rumley A, Cherry L, Whincup PH, Sattar N. Adipokines and risk of type 2 diabetes in older men. Diabetes Care 2007 30 1200-1205
10. Marmot M, Brunner E. Cohort Profile: the Whitehall II study. Int J Epidemiol 2005 34 251-256
11. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997 20 1183-1197
12. Kumari M, Head J, Marmot M. Prospective study of social and other risk factors for incidence of type 2 diabetes in the Whitehall II study. Arch Intern Med 2004 164 1873-1880
13. De Jager W, te Velthuis H, Prakken BJ, Kuis W, Rijkers GT. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 2003 10 133-139
14. Koebnick C, Roberts CK, Shaibi GQ, Kelly LA, Lane CJ, Toledo-Corral CM, Davis JN, Ventura EE, Alexander K, Weigensberg MJ, Goran MI. Adiponectin and leptin are independently associated with insulin sensitivity, but not with insulin secretion or beta-cell function in overweight Hispanic adolescents. Horm Metab Res 2008 40 708-712
15. Thamer C, Haap M, Heller E, Joel L, Braun S, Tschritter O, Haring H, Fritsche A. Beta cell function, insulin resistance and plasma adiponectin concentrations are predictors for the change of postprandial glucose in non-diabetic subjects at risk for type 2 diabetes. Horm Metab Res 2006 38 178-182